Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy

Background: Several studies have demonstrated the antitumor activity of rosiglitazone (RGZ) in cancer cells, includ- ing breast cancer cells. However, the molecular targets of RGZ in the inhibition of angiogenesis in breast cancer cells remain unclear. This study aimed to explore the potential tar...

Full description

Saved in:
Bibliographic Details
Main Authors: Hermawan, Adam, Putri, Herwandhani
Format: Article PeerReviewed
Language:English
Published: Springer 2022
Subjects:
Online Access:https://repository.ugm.ac.id/278720/1/Hermawan_FA.pdf
https://repository.ugm.ac.id/278720/
https://bmcgenomdata.biomedcentral.com/articles/10.1186/s12863-022-01086-2
https://doi.org/10.1186/s12863-022-01086-2
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Gadjah Mada
Language: English
Be the first to leave a comment!
You must be logged in first